Fennec Pharmaceuticals Inc. FENC 深 沪
等待开盘 07-06 09:30:00 美东时间
10.70
+0.360
+3.48%
华盛通- 最 高10.88
- 今 开10.35
- 成交量 14.05万股
- 最 低 10.30
- 昨 收 10.34
- 总市值 37.17万
- 52周最高 11.31
- 市盈率 静 --
- 换手率 0.40%
- 52周最低 5.65
- 委 比 6.72%
- 总股本 3.47万
- 历史最高 14.986
- 量 比 0.35
- 振 幅 5.61%
- 历史最低 3.255
- 每 手 1
- 风险率 1.01%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Fennec Pharmaceuticals shareholders elect directors at annual meeting
Fennec Pharmaceuticals shareholders elect directors at annual meeting Fennec Pharmaceuticals held its annual general and special shareholder meeting online on June 10, 2025. Shareholders adopted a resolution appointing Haskell & White LLP as auditor, authorizing the board to set the auditor’s remune
06-15 18:03
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Fennec Pharmaceuticals Inc. granted 10,000 incentive stock options to a new non-executive employee under its 2026 Equity Inducement Plan. The options, exercisable at $9.00 per share, vest over three years and expire in ten years. Fennec focuses on reducing cisplatin-induced ototoxicity in cancer patients with its FDA-approved PEDMARK®. The company has partnered with Norgine to commercialize PEDMARQSI® in Europe and other regions.
06-15 10:00
HC Wainwright & Co. Maintains Buy on Fennec Pharmaceuticals, Raises Price Target to $16
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the price target from $13 to $16.
05-22 18:49
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting
Fennec Pharmaceuticals announced new research on PEDMARK® (sodium thiosulfate injection) at the 2026 ASCO Annual Meeting, showcasing its potential benefits for broader patient populations, including adolescents, adults, and those with head and neck cancers. Four independent studies highlight PEDMARK's safety, efficacy, and feasibility in reducing cisplatin-induced ototoxicity without compromising antitumor activity. Results demonstrate significan...
05-21 22:01
美股牛股 | 股价狂飙超68%！AI芯片新星Cerebras首日表现惊艳；光通信牛股POET涨超43%
股价狂飙超68%！AI芯片新星Cerebras首日表现惊艳；光通信牛股POET涨超43%，此前披露光引擎采购大单；无人机公司ONDS涨逾26%，Q1营收同比暴增逾十倍>>
05-15 19:10
Fennec Pharmaceuticals shares are trading higher. The company reported Q1 financial results.
Fennec Pharmaceuticals shares are trading higher. The company reported Q1 finan...
05-15 03:30
Fennec Pharmaceuticals Reports Q1 2026 Results: Full Earnings Call Transcript
Fennec Pharmaceuticals (NASDAQ:FENC) released first-quarter financial results a...
05-14 21:32
Earnings Scheduled For May 14, 2026
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
Fennec Pharmaceuticals Q1 sales rise 73% on PEDMARK demand
Fennec Pharmaceuticals Q1 sales rise 73% on PEDMARK demand Overview US specialty pharma's Q1 product sales rose 73% yr/yr on higher PEDMARK adoption Company posted net income of $201,000, reversing a loss a year ago Growth driven by expanded field sales and increased demand for PEDMARK Outlook Compa
05-14 18:41
